<DOC>
	<DOCNO>NCT00898521</DOCNO>
	<brief_summary>Burns represent one severe dread trauma . Burned traumatized tissue know eschar . The dead eschar , remove , often become heavily contaminate source local and/or systemic infection sepsis . The local inflammation infection destroy healthy surround tissue extend original damage . In order prevent complication , order minimize risk infection , imperative evaluate burn remove offend eschar early possible opportunity . This removal dead tissue term `` debridement '' . The direct debridement method eschar removal surgery . Traditional , conservative non-surgical debridement lengthy process often involve many complication . The objective study follow : 1 . To evaluate safety efficacy ( exploratory ) DGD hospitalize patient Partial Thickness ( mid deep dermal ) thermal burn 4-30 % total body surface area ( TBSA ) , total burn wound 30 % TBSA . Measures already take previous study involve deep wound control safety parameter ( pain , fever infection ) . Nevertheless , part effort expand burn population future phase 3 study superficial wound group , important first explore parameter small group involve burn population . 2 . To explore DGD absorption measure Pharmacokinetic testing .</brief_summary>
	<brief_title>Feasibility Study : Enzymatic Debridement Patients With Partial Thickness Burns</brief_title>
	<detailed_description>on-going recruitment , child adult</detailed_description>
	<mesh_term>Burns</mesh_term>
	<criteria>1 . Males females 2 year 55 year age , 2 . Thermal burn cause fire/flame , scald contact , 3 . Burn composition must follow : 1 . Partial Thickness ( mid &amp; deep dermal ) burn wound ≥ 4 % ≤ 30 % Total Body Surface Area ( TBSA ) , 2 . Full thickness burn ≤ 5 % , 4 . All partial full thickness burn wound must receive study treatment except facial , genital perineal burn ( Exclusion Criteria # 5 # 6 ) , 5 . Total burn wound ≤ 30 % TBSA , 6 . Hospital admission within 24 hour burn injury . Patients transfer another hospital/clinic may enrol primary admission within 24 hour burn injury admission burn unit participate study within 48 hour burn injury , 7 . Signed write informed consent . 1 . More 5 % TBSA full thickness burn , 2 . Patient full thickness burn , 3 . Other severe cutaneous trauma site burn ( i.e . considerable blunt , avulsion deep abrasion ) , previous burn ( ) treatment site ( ) , 4 . One burn wound meet study criterion , 5 . Deep partial thickness and/or full thickness facial burn wound &gt; 0.5 % TBSA ; study treatment facial burn allow , 6 . Study treatment perineal and/or genital burn allow ; A patient wound may enrol wound may designate target wound , 7 . Patient circumferential anterior/posterior trunk fire/flame burn , &gt; 15 % TBSA Circumferential define encircle ≥ 80 % trunk circumference ) , 8 . A . The following pre enrolment dressing : a. Flammacerium , b . Silver Nitrate AgNO3 ) , B. Preenrolment wound covered eschar heavily saturate iodine pseudoeschar ( e.g . pseudoeschar result SSD treatment ) ; 9 . Preenrolment escharotomy , 10 . Heavily contaminate burn preexist infection ( Adults : WBC ≥ 20.0 X 103 cells/µL ; Children age 418 : WBC ≥ 25.0 X 103 cells/µL ) ) ,11.Signs may indicate smoke inhalation ( e.g . clinical sign , etiology injury , venue injury , etc . ) , 11 . Children Hb &lt; 10 gm/dl Screening/Pre treatment 12 . Prisoners , 13 . Pregnant woman ( positive pregnancy test ) nursing mother , 14 . Poorly control diabetes mellitus ( HbA1c &gt; 9 % ) , 15 . Cardiopulmonary disease ( MI within 4 week prior injury , pulmonary hypertension , COPD preexist oxygendependent pulmonary disease ) , 16 . Preexisting disease interfere circulation ( PVD , edema , lymphedema , surgery regional lymph node , obesity , varicose vein ) , 17 . Immediate life threaten condition ( immunocompromising disease , life threaten trauma , severe preexist coagulation disorder , cardiovascular , liver neoplastic disease ) , 18 . Chronic systemic steroid intake , 19 . History allergy and/or know sensitivity pineapple papain , 20 . Current suicide attempt , 21 . Participation another investigational drug trial , 22 . Current alcohol drug abuse ,</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>